Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Andrew R. Moore; Malcolm Boyce; Islay A. Steele; Fiona Campbell; Andrea Varro; D. Mark Pritchard

doi:10.1371/journal.pone.0076462

Loading metrics

Open Access

Peer-reviewed

Research Article

Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Andrew R. Moore,

Affiliations Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom, Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
⨯
Malcolm Boyce,

Affiliation Hammersmith Medicines Research, London, United Kingdom
⨯
Islay A. Steele,

Affiliation Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
⨯
Fiona Campbell,

Affiliation Department of Pathology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom
⨯
Andrea Varro,

Affiliation Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
⨯
D. Mark Pritchard

* E-mail: mark.pritchard@liverpool.ac.uk

Affiliation Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
⨯

Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Andrew R. Moore,
Malcolm Boyce,
Islay A. Steele,
Fiona Campbell,
Andrea Varro,
D. Mark Pritchard

Published: October 1, 2013
https://doi.org/10.1371/journal.pone.0076462

Reader Comments

Post a new comment on this article

Figure 4 error

Posted by szhang499 on 08 Jul 2016 at 18:33 GMT

This figure is identical to Figure 5 and doesn't match the legend.

No competing interests declared.

RE: Figure 4 error

mpritchard replied to szhang499 on 13 Jul 2016 at 09:29 GMT

This error was noted at the time of initial publication. A correction was published on the website on 1 Nov 2013 and the correct version of figure 4 is shown there. Mark Pritchard 13 July 2016.

No competing interests declared.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Gastrin
Is the Subject Area "Gastrin" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Gastric cancer
Is the Subject Area "Gastric cancer" applicable to this article?

Thanks for your feedback.
Endoscopy
Is the Subject Area "Endoscopy" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.

Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

Figure 4 error

Posted by szhang499 on 08 Jul 2016 at 18:33 GMT

RE: Figure 4 error

mpritchard replied to szhang499 on 13 Jul 2016 at 09:29 GMT